BioSpace News Archive

Bayer announced today that new NUBEQA® (darolutamide) and Xofigo® (radium Ra 223 dichloride) data will be presented at the 2021 American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place from February 11-13, 2021.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, today announced the appointment of Susan Moriconi as VP of People and Chief Human Resources Officer.

Scopus BioPharma Inc. announced that the underwriters of the company’s follow-on public offering exercised their over-allotment option in full, bringing total proceeds to $10.35 million.

RespireRx Pharmaceuticals Inc., has been up listed from the OTC Pink Market and returns to the OTCQB Venture Market, effective with opening of the markets , Monday, February 8, 2021.

Zomedica Corp. announced that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 91,315,790 common shares of Zomedica, at a price to the public of $1.90 per share, less underwriting discounts and commissions.

Geographically, the global hyperemesis gravidarum treatment market is segmented into North America, Latin America, Europe, CIS & Russia, Asia-Pacific Excluding Japan, Japan and the Middle East & Africa.

Fact.MR, a global research & consulting firm, in their updated edition of the report, states that the colored contact lenses market is projected to record a robust growing pace in 2021 & beyond.

The catheters that are utilized to access the patient’s vascular system through veins are known as intravenous catheters. These catheters are thin tubes that are used to serve various medical purposes such as use in administration of medications, surgical procedures, removal of body fluids, and treating diseases.

The global biologics safety testing market is foreseen to increase growth on the back of the rising number of drug launches and research and development investment in the life sciences industry.

Increased number of research activities in all worldwide locations is projected to boost the expansion of the global polyclonal antibody market throughout the forecast period 2020–2030.